More insights, better patient health
Shorten the diagnostic window for patients with rare diseases with our comprehensive testing platform
By the numbers
421+
Lorem ipsum dolor sit amet
Korem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis.
421+
Lorem ipsum dolor sit amet
Korem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis.
421+
Lorem ipsum dolor sit amet
Korem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis.
421+
Lorem ipsum dolor sit amet
Korem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis.
RareVision
RareVision is a whole genome sequencing test for patients who are looking for a clearer diagnosis of a rare disease or answers about their symptoms that could be genetically related.
Who is RareVision for?
This test is for patients or family members who are looking for a clearer diagnosis of a rare disease or answers about their symptoms that could be genetically related. Some of them may be curious about their genetic health or suspect they have a rare disease. Our whole genome test uses one of the most up-to-date rare disease databases to provide accurate results and clear answers for patients. We offer you and your patients whole genome coverage, actionable findings, and expert support to provide the best care possible.
We relieve your diagnostic burden so you can spend more time caring for your patients
Our goal is to be a resource for you beyond top-tier genetic testing. We’re here to provide and translate complex data and findings to turn them into actionable insights to support your patients.
Increased diagnostic yield
In a sensorineural hearing loss patient cohort, our RareVision whole genome test identified 23.6% more rare disease patients who were not previously diagnosed with PCR tests, targeted panel sequencing, whole exome sequencing and ctDNAseq.
High clinical utility
RareVision can detect pathogenic variants that standard panel tests may have missed. RareVision achieved a 31.2% diagnosis rate in a group of 5,000 previously undiagnosed or wrongly diagnosed individuals.
How to order a test
Ordering a test is quick and easy at our provider order portal
01.
Start an online order by filling out the test requisition form. We will send our kits to your office.
02.
Use our supplied sample collection kit and instructions to collect samples for testing.
03.
Ship the samples directly to us.
04.
Receive the test results via email and fax. You can also access all test results you ordered in our online portal
Test requirements
Specimen
Peripheral blood (3-5 mL)
Turnaround time
2 weeks from receipt of patient samples at our lab
Featured resources
Frequently asked questions
If you don’t see your question answered here, please contact us at inquiry@inocras.com.
How do I order a RareVision test?
To order a test, please complete the online test requisition form. Our sales representatives will follow up with you shortly.
How are the tests paid for?
Unfortunately, our tests are not currently covered by insurance. Upon ordering, your patient will receive an invoice for which payment will be required directly from the patient’s out-of-pocket expenses.
How will I receive the results?
You can access Inocras test reports as soon as they are ready via our digital reporting portal. You can also receive access to results via secure email or request to have results faxed to you.
What if I have questions about my patient’s results?
You’ll have access to our team of in-house medical experts, researchers, and genomic specialists who can explain the results to you and answer any questions. If you have questions about a patient’s results, you can email us at inquiry@inocras.com for support. One of our experts will respond to your questions or set up time to speak with you.